Given the data and tweets, could you project whether the closing price of $bmy will grow or shrink at 2017-07-12? Please specify either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-06-27,1.6,1.7,-0.1,-1.8,-1.8,1.2,-0.4,-1.6,-2.3,-2.5,-2.6
2017-06-28,0.5,0.9,-0.2,-0.1,-0.1,1.2,-0.1,-1.2,-2.1,-2.3,-2.5
2017-06-29,0.2,0.6,-0.6,-0.1,-0.1,0.7,0.3,-0.8,-1.9,-2.1,-2.3
2017-06-30,0.5,0.6,-0.1,-0.2,-0.2,0.6,0.7,-0.3,-1.6,-1.8,-2.0
2017-07-03,0.0,1.1,-0.2,1.0,1.0,-0.6,-0.1,-1.1,-2.3,-2.6,-2.8
2017-07-05,-0.1,0.1,-1.4,0.1,0.8,-1.2,-0.7,-1.6,-2.6,-3.2,-3.5
2017-07-06,1.5,1.7,-0.1,-1.9,-1.9,0.7,1.1,0.4,-0.5,-1.2,-1.5
2017-07-07,-0.7,0.2,-1.5,1.1,1.1,-0.3,-0.2,-0.5,-1.3,-2.2,-2.5
2017-07-10,0.3,0.7,-0.2,0.0,0.0,-0.1,-0.3,-0.3,-1.1,-2.2,-2.4
2017-07-11,0.9,1.4,-0.4,-1.1,-1.1,0.8,0.6,0.9,0.1,-0.9,-1.3

2017-06-27: #bristolmyerssquibb bristol-myers reports data on immuno-oncology drug empliciti. read more:  $bmy|#bristolmyerssquibb bristol-myers reports data on immuno-oncology drug empliciti. read more:  $bmy|rt
2017-06-28: rt AT_USER #mystic study success could put $azn ahead in #cancer revolution #biotech #pharma $mrk $rhhby $bmy  via¡­|rt AT_USER #mystic study success could put $azn ahead in #cancer revolution #biotec
2017-06-29: rt AT_USER AT_USER AT_USER AT_USER ceo you will want to speak linda powers AT_USER $nwbo about to shock #wa¡­|rt AT_USER AT_USER AT_USER AT_USER ceo you will want to speak linda powers AT_USER $nwbo a
2017-06-30: should we be interested in astrazeneca in 2017?  $azn $bmy $mrk $pfe|AT_USER AT_USER AT_USER imho $ptla gets taken out soon.  beyxxa was key approval. $pfe &amp; $bmy have¡­ |bristol-myers squibb comp
2017-07-01: rt AT_USER AT_USER AT_USER AT_USER don't see mystic positive or negative result a positive for $bmy. positive, one more io/io¡­|AT_USER AT_USER AT_USER as of $bmy share price, really depends on how mu
2017-07-02: benzinga: barron's picks and pans: bristol-myers, texas instruments, altaba and more  $aaba $bmy $ftr|barron's picks and pans: bristol-myers, texas instruments, altaba and more  $aaba $bmy $ftr|   cra
2017-07-03: early movers in monday's market   $tsla $wynn $cat $lvs $gs $gsk $bmy #tesla #wynn #goldman #glaxosmithkline|rt AT_USER other notable imbalances: $nke -351k, $clx -50k, $bmy +107k, $yum -80k, $gis -92
2017-07-04: bristol-myers squibb company $bmy downgraded to hold at bidaskclub |bristol-myers squibb company $bmy downgraded to hold at bidaskclub |rt AT_USER cites AT_USER and report by AT_USER me and the rest o
2017-07-05: rt AT_USER AT_USER AT_USER adam maybe you missed AT_USER $nwbo has phase 3 #glioblastoma reads out now collaborate¡­|rt AT_USER AT_USER AT_USER adam maybe you missed AT_USER $nwbo has phase 3 #gliobla
2017-07-06: not all pd1/pd-l1 the same ($mrk and $bmy amongst others) but $celg deal with $bgne - is this really a good use of company resources?|rt AT_USER AT_USER AT_USER adam maybe you missed AT_USER $nwbo has
2017-07-07: AT_USER AT_USER AT_USER AT_USER AT_USER any indication with an approved c.p. inhibitor will be op¡­ | members have an advantage. see track record  $bmy $pot $apa $cnq $ccl $ba| members have an advanta
2017-07-08: #bristolmyerssquibb us fda approves bristolmyers squibb's orencia to treat adults patients w... read more:  $bmy|#bristolmyerssquibb us fda approves bristolmyers squibb's orencia to treat adults patie
2017-07-09: rt AT_USER market cap top 25 pharma biotech $ibb $jnj $mrk $celg $gild $bmy $incy $spy |rt AT_USER market cap top 25 pharma biotech $ibb $jnj $mrk $celg $gild $bmy $incy $spy |appleton partners inc. m
2017-07-10: biotech &amp; pharmaceuticals stocks $bmy $sny $rhhby $mrk $lly $roth $zfgn $vktx $jnj $ilmn  $tgtx $lxrx $alks $ibb¡­ |rt seekingalpha "brunch, craft beer, and investing: a millennial's portfolio  $a
2017-07-11: biggest cancer drugs of 2022 #stocks $pfe, $mrk, $jnj, $bmy, $celg, $abbv |rt AT_USER today's isee opening customer buyers: $wfm $ter $asml $uso $qep $dba $ewz $xlf $wdc $svxy $kr $bmy |today's isee o
Answer:
Fall